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I. Introduction 
Achilles tendon rupture is a common sports injury [1]. It takes time for the tendon 
to heal after such an injury, and often 6-9 months are needed before the athlete 
can resume sports activity [2,3]. Several methods to accelerate tendon healing are 
currently being tested, including treatment with atelocollagen and boric acid [4,5]. 
However, no definitive method exists, save early exercise therapy [6]. Platelet 
rich plasma (PRP) is blood plasma enriched in platelets obtained by centrifugally 
separating blood and contains a high concentration of growth factors. Platelets 
contain over 300 physiologically active proteins, including vascular endothelial 
growth factor (VEGF), fibroblast growth factor (FGF), platelet-derived growth 
factor (PDGF), and transforming growth factor beta (TGFb), and these factors can 
potentially encourage tendon healing [7-10]. However, the research results in 
animals and humans regarding the effects of PRP on Achilles tendon healing are 
inconsistent [8-11]. It is speculated that this may be due to a lack of standardized 
quality for PRP preparations, including the presence of white blood cells in PRP, 
the number of centrifugal separations, and varying enrichment factors. DeLong 
advocated PAW classification [12], which is a classification based on PRP 
components and activation methods, but very few studies have investigated the 
effects of various concentrations of PRP on tendon healing. There is no consensus 
on the most appropriate platelet concentration in PRP. 
The objective of this research is to mechanically and histologically evaluate the 
capacity of different PRP concentrations to promote tendon healing.  
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II. Materials and Methods 
Animals:  
All animal experimentation protocols were approved by the Ethics Committee of 
this institution and are in accordance with the Animal Experimentation 
Management and Use Guidelines of the National Institutes of Health.  
Mature New Zealand white rabbits (age, 24-26 weeks; weight, 2.8-3.6 kg) were 
used in this study. All rabbits were randomly grouped into three groups. In 20 
rabbits (L-PRP group, 40 hindlimbs), 1.0 mL of low-concentration PRP was 
applied to the Achilles tendon tear transection site as described in the next section. 
The other 20 rabbits (H-PRP group, 40 hindlimbs), 1.0 mL of high-concentration 
PRP was applied to the tear transection site. In the remaining 20 rabbits (S group, 
40 hindlimbs), 1.0 mL of physiological saline. Finally, 6 rabbits (C group, 12 
hindlimbs) served as controls, and these animals did not have transected Achilles 
tendons. The number of animal subjects and amounts of administered PRP were 
based on previous reports [13-16]. Ten rabbits from each group were slaughtered 
at 4 and 8 weeks following the transection surgery, with subsequent histological 
evaluation of the right legs, and mechanical evaluation of the left legs.  
 
PRP Preparation: 
PRP is defined as the plasma layer fraction rich in platelets formed by centrifuging 
blood [17]. Rabbits were intramuscularly injected with a mixture of 
medetomidine hydrochloride (0.5 mg/kg, Domitor, Nippon Zenyaku Kogyo, 
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Japan), midazolam (2.0 mg/kg, Dormicum, Astellas Pharma, Japan), and 
butorphanol tartrate (0.5 mg/kg, Betorfal, Meiji Seika Pharma, Japan) to induce 
anesthesia. Blood (highest possible volume) was drawn from the pericardium with 
an 18-gauge needle. Immediately after collection, the blood was transferred into 
tubes containing anticoagulants. The collected blood was utilized to prepare low-
concentration (10 mL) PRP (L-PRP), high-concentration (40 mL) PRP (H-PRP), 
and 2 mL was reserved for blood counts. The PRP was prepared by centrifugation 
(once) using a commercial platelet separation kit (MyCells Autologous Platelet 
Preparation System, Kaylight, Ramat-Hasharon, Israel). In accordance with 
previous reports, the centrifugation time was 10 minutes at 1500 G. L-PRP (2.5 
mL) was prepared from 10 mL of whole blood, and H-PRP (2.5 mL) was prepared 
from 40 mL of whole blood [18]. Platelet activation, was induced in PRP 
preparations by treatment with 0.2% CaCl2 to cause gelation [19]. We 
administered 1.0 mL of PRP to each hindlimb in the PRP group. Whole blood and 
any remaining PRP were used to calculate platelet, white blood cell, and red blood 
cell counts using a hemocytometer (MEK-6358 Celltac α, Nihon Kohden, Tokyo, 
Japan).  
 
Achilles Tendon Transection Model: 
Rabbits were anesthetized as described above. After creating a vertical incision in 
the skin, the paratenon was split vertically, exposing the Achilles tendon. The 
Achilles tendon was horizontally transected approximately 2 cm from its 
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calcaneal attachment point. The plantar fascia was untouched and allowed to serve 
as an internal splint [13]. Subsequently, the L-PRP and H-PRP groups were treated 
with 1.0 mL of PRP (of the appropriate concentration) at the tendon rupture site. 
The S group, was treated with the same volume of physiological saline instead of 
PRP. After administration of either PRP or saline, the paratenon and the animal’s 
skin were sutured closed with 4-0 nylon, and this procedure was carried out on 
both hindlimbs of each animal. After surgery, animals were returned to their cages 
and allowed to move about freely. 
 
Histological Evaluation:  
Histological evaluations were conducted at 4 and 8 weeks after treatment with 
PRP or physiological saline. The right Achilles tendon was removed and separated 
from the surrounding tissue. Samples were fixed in a buffered 10% formalin 
solution and embedded in paraffin blocks. Sections were cut at 4 mm intervals 
along the sagittal plane of the Achilles tendon. Two paraffin sections were created 
at the center of the healing area for each tendon and one was stained with 
hematoxylin eosin, while the other was stained with Masson Trichrome. We 
performed histopathological analysis of the Achilles tendon by utilizing the semi-
quantitative Bonar scale [20]. This scale consists of four subscales, each scored 0, 
1, 2, or 3, where 0 is normal and 3 is maximally abnormal. Scale one evaluates 
the presence of tendon cell morphology and proliferation, two evaluates the 
presence or absence of the intercellular matrix, three the characteristics of the 
 6 
collagen bundle, and four, angiogenesis (Table 1). The overall Bonar scales were 
calculated as the sum of each subscale score. The area with the most marked 
pathological change, at the center of the tendon healing area on each slide, was 
selected for evaluation. Each histological analysis was performed separately by 2 
different orthopedic surgeons who were blinded to the group allocations with 5 
years of experience each, and the mean Bonar scale score was designated as the 
final value. The interclass correlation coefficient between observer measurements 
was 0.85.  
 
Mechanical Evaluation: 
Mechanical evaluations were conducted at 4 and 8 weeks following treatment 
with PRP or physiological saline. The left Achilles tendon of each animal was 
extracted alongside the calcaneus and gastrocnemius soleus. Using specially 
designed equipment, clamps were attached to the calcaneus and the gastrocnemius 
soleus (40 mm away from the attachment of the Achilles tendon to the calcaneus), 
and placed 40 mm apart from each other (Autograph AG-X mechanical testing 
apparatus, Shimadzu Corp., Kyoto, Japan). Prior to testing, samples were 
preloaded with 5 N of force at 24±1℃ for 5 minutes to align the collagen fibers 
[21,22]. Following the preloading, samples were pulled at a rate of 10 mm/min, 
and the ultimate load (N), ultimate stress (MPa), elastic modulus (MPa), and 
stiffness (N/mm) were determined [23,24]. Elastic modulus was calculated to 
correspond to 20% to 80% of ultimate stress [25]. Stiffness was calculated as the 
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slope of the load-displacement curve corresponding to 20% to 80% of the ultimate 
load [25].  
 
Statistical Analysis:  
The white blood cell and platelet counts of PRP preparations were expressed as 
the median (25th–75th percentile), histological and mechanical assessments were 
expressed as mean ± standard deviation. The white blood cell and platelet counts 
of PRP preparations were compared using the Kruskal-Wallis test and the Tukey-
Kramer test was used for post-hoc analysis. 
Changes over time, and the differences in treatment effects for each evaluation 
metric were calculated using a linear mixed-effects model. The number of weeks 
after the surgery and evaluation metrics were set as dependent variables, the 
random effect was set as each animal, and the correlation between variables was 
investigated. A linear mixed-effects model was used to calculate statistics with the 
commercial SAS software package (SAS Institute, Sally, NC, USA), and 
BellCurve for Excel (Social Survey Research Information Co., Ltd, Japan) was 
utilized for other tests. The P-value threshold for statistical significance was set 
to 0.05.  
 
Bioethical approval  
All experimental procedures in this study were approved by the Animal 
Experiment Committee of Chiba University (Approval No. 30-330), and were 
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conducted in accordance with the Guidelines for Proper Conduct of Animal 
Experiments of the Science Council of Japan. 
 
 
III. Results 
Blood Cell Count: 
Platelet counts were 84.2 (56.4-99.9) (x 10⁴/μl) for L-PRP, and 284.2 (192.1-
328.1) (x 10⁴/μl) for H-PRP, and both were significantly higher than the platelet 
counts for whole blood [22.1 (17.5-25.0) (x 10⁴/μl)] (P < 0.001); specifically, 3.8 
and 12.8 times higher, respectively. White blood cell counts were 2010 (1540-
3200) (/μl) for L-PRP, and 2290 (1530-3380) (/μl) for H-PRP; both figures were 
lower than the count for whole blood [3085 (1510-4510) (/μl)], but no significant 
difference was observed between the three groups (P = 0.51).  
 
Histological Evaluation: 
Tendon cell morphology, intracellular matrix volume, collagen arrangement, and 
blood vessel numbers were evaluated. As tendon healing progressed, the number 
and size of tendon cells decreased, as did the size of the intracellular matrix. 
Collagen fibers began to be arranged in parallel along their long axes. The number 
of blood vessels decreased (Figure 1). Bonar scale values decreased significantly 
from the 4th to the 8th week (P = 0.01). Bonar scales decreased from the S to L-
PRP to H-PRP groups (Table 2), and a significant difference in treatment effect 
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was observed between the groups (P = 0.03).  
 
Mechanical Evaluation: 
The transected cross-sectional area, ultimate load (N), ultimate stress (MPa), 
elastic modulus (MPa), and stiffness (N/mm) were evaluated. The transected 
cross-sectional area, ultimate load (N), ultimate stress (MPa), elastic modulus 
(MPa), and stiffness (N/mm) for the control group were 20.4±4.2 (cm2), 
215.4±71.1 (N), 10.4±3.4 (MPa), 106.9±29.3 (MPa), and 71.8±17.5 (N/mm), 
respectively. The transected cross-sectional area decreased significantly from the 
4th to the 8th week in each group (P < 0.001). The ultimate stress, elastic modulus, 
and stiffness increased significantly from the 4th to the 8th week. The values for 
ultimate load, ultimate stress, elastic modulus, and stiffness increased from the S 
to L-PRP to H-PRP groups (Table 3). A significant difference in treatment effect 
was only observed between the groups for stiffness (P = 0.03).  
 
 
IV. Discussion 
In this study, Bonar scale values were highest for the S group, followed by the L-
PRP group, and were lowest in the H-PRP group, indicating that histological 
evidence for promotion of tendon healing was most pronounced for high-
concentration PRP preparations. The mechanical analyses also revealed that 
promotion of tendon healing evidence was highest in the H-PRP group, followed 
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by the L-PRP group, and was lowest for the S group. A significant difference was 
observed for stiffness.  
PRP is plasma enriched in platelets, and contains a high concentration of growth 
factors, which can potentially promote tendon healing. However, a consensus on 
the most appropriate concentration of platelets has not been reached. The PAW 
classification system of PRP is based on 3 components: (1) the absolute number 
of Platelets, (2) the manner in which platelet Activation occurs, and (3) the 
presence or absence of White cells [12]. Platelet concentration categorized as 
follows: P1, less than or equal to baseline levels; P2, greater than baseline levels 
to 750,000 platelets/μL; P3, greater than 750,000 to 1,250,000 platelets/μL; and 
P4, greater than 1,250,000 platelets/μL. In this classification, L-PRP in this study 
is classified as P3, and H-PRP is classified as P4. Ours is the first report on the 
tendon-healing-promotion effects of different concentrations of PRP, in a rabbit 
model of Achilles tendon transection. Mastrangelo et al. reported no significant 
difference between platelet concentrations of 3x and 5x in the mechanical healing 
of a sutured ACL in animal models [26]. However, the difference in concentration 
between the two conditions was rather small. We used concentrations of 3.8x and 
12.8x, and found that stiffness was significantly higher for the high-concentration 
group, likely because our PRP concentrations differed by a wider margin. While 
a significant difference in treatment effect between the three groups was only 
observed for stiffness, stiffness has been reported as the most clinically important 
structural characteristic for tendons and ligaments [27-29], and we believe that 
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PRP concentration had an effect on its capability to promote mechanical healing 
of the affected tendon.  
In this study, high-concentration PRP preparations were better for the promotion 
of histological and mechanical healing of affected tendons. Platelet and growth 
factor concentrations are reportedly proportional to one another [30,31]. This 
suggests that the H-PRP preparations in our study contained a higher level of 
growth factors, possibly enhancing the promotion of tendon healing. Increasing 
the number of centrifugations, speed, and running time can increase the 
enrichment factor (concentration) of PRP preparations [12], but these more 
vigorous extraction procedures can damage platelets, and cause depletion of 
necessary growth factors for tissue healing. In this study, we minimized the effect 
of the extraction process on the integrity of platelets in the low- and high-
concentration PRP preparations by not altering the centrifugation parameters, and 
instead using more blood for the H-PRP preparation to yield a higher number of 
platelets.  
Our research has several limitations. 
First, the number of tendons we examined was relatively small (10 per group, per 
timepoint). While the number of animals sacrificed for the purpose of this 
research should be kept to a minimum, further investigations that make use of 
more samples would strengthen our findings. 
Second, we did not evaluate the growth factor concentrations in our PRP 
preparations. However, even though we did not directly measure the growth factor 
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concentrations in the H-PRP and L-PRP preparations, previous reports showed 
that platelet and growth factor concentrations were proportional to each other, and 
the extraction processes used to prepare both types of PRP used in our study were 
the same as previously reported. Thus, we can expect that the growth factor 
concentration was higher in the H-PRP than in the L-PRP preparations.  
Third, we administered physiological saline to the surgery site in our control 
group, instead of PRP. Lyras et al. [33] also injected their study control group with 
physiological saline; however, it is possible that saline has an effect on the tendon 
healing process. In addition, since we transected Achilles tendons and 
administered PRP and saline without taking time, local bleeding may affect the 
results. 
Fourth, in our statistical analyses, we treated the two Achilles tendons from each 
rabbit as independent from one another. However, it is quite possible that the 
healing processes in two different tendons from a single rabbit are related. 
However, from an animal welfare standpoint, keeping the number of rabbits used 
in our study to a minimum required using the tendons on both legs. 
Fifth, a rabbit model of Achilles tendon rupture will differ from a clinical model 
of Achilles tendon rupture in humans. Thus, it may well be the case that our 
findings with respect to PRP concentration do not directly translate to the clinical 
treatment for a ruptured Achilles tendon in human patients. However, the main 
objective of this research was to compare the effect of different concentrations of 
PRP preparations. Furthermore, we must keep in mind that the mechanical and 
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histological analysis of Achilles tendon rupture in human subjects is ethically 
questionable and technically difficult.  
In conclusion, We evaluated the potential of different PRP concentration 
preparations to promote tendon healing in a rabbit Achilles tendon transection 
model. Our results showed that PRP preparations with a high concentration of 
platelets were superior in the promotion of histological and mechanical healing 
of the Achilles tendon.  
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Figure legends 
Figure 1    Photomicrographs of the Achilles tendon 
A–F, Photomicrographs of the Achilles tendon (Masson trichrome stain; original 
magnification, ×100). Representative images from, A–C, 4-week postoperative 
period (A: C group, B: L-PRP group, C: H-PRP group) and, D–F, 8-week 
postoperative period (D: C group, E: L-PRP group, F: H-PRP group) are shown. 
 
Table 1    Bonar Scale 
Reproduced from Reference 20 with permission. 
 
Table 2    Bonar Scales for the Achilles Tendon 
Data are means ± standard deviations for ten rabbit limbs per group. There was a 
significant effect of time (P = .01) and significant effect of treatment (P = .03) on 
the Bonar scale. 
 
 
Table 3    Mechanical Assessment for the Achilles Tendon 
Data are means ± standard deviations for ten rabbit limbs per group. There were 
significant effects of time except Ultimate load. There was a significant effect of 
treatment (P = .03) on the Stiffness. 
 19 
 
 
Figure 1 
 
 
 
 
 
 
 
 
 
 
 
 
 20 
Table 1 
 
 
Table 2 
 
 
Table 3 
 
 21 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chiba Medical Journal vol.96 No3 
2020年 6 月 10日 公表予定 
